Spectagraph

Japan-based medical technology company Spectratech has developed its fNIRS device, OEG-16H, an encephalography mechanism to measure changes in hemoglobin and apparent arterial oxygen saturation in the frontal lobe of comatose patients.

The device is based on Spectratech-developed Ultrahigh SNR technology which can display ultra-weak pulse waves and allow users the ability to perform a multi-channel brain localisation analysis.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Its index of Apparent SpO2 (apparent arterial oxygen saturation) facilitates a better understanding of how to influence the actions from cerebral circulation / metabolism to brain function by the Ultrahigh SNR technology.

The easy to carry, battery-operated device includes a monitor, a main unit, head modules, software, optical phantom, BNC cable for external input, manual event trigger input, USB cable, and an AC adapter.

The Spectratech OEG-16 H can operate on Microsoft Windows 7 or 8 and its own dedicated software.

See Also:

"The device translates brain waves into data allowing a simultaneous measurement of hemoglobin at multiple points."

The instrument offers constant connectivity with six light injection points, six optical light-receiving points, and 16-channel measure points in the lightweight head module.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The device translates brain waves into data allowing a simultaneous measurement of hemoglobin at multiple points.

Additionally, the distributor allows medical technicians to implement hyperscanning.

Spectratech aims to interpret chemical changes in the brain by means of this fNIRS technology to establish patterns of communication with comatose patients.

Image: The Spectratech OEG-16 H tin use. Photo: courtesy of PRNewsFoto / Ampronix.